| Literature DB >> 26866058 |
Andy D Weyer1, Katherine J Zappia1, Sheldon R Garrison2, Crystal L O'Hara1, Amanda K Dodge1, Cheryl L Stucky1.
Abstract
Peripheral inflammation causes mechanical pain behavior and increased action potential firing. However, most studies examine inflammatory pain at acute, rather than chronic time points, despite the greater burden of chronic pain on patient populations, especially aged individuals. Furthermore, there is disagreement in the field about whether primary afferents contribute to chronic pain. Therefore, we sought to evaluate the contribution of nociceptor activity to the generation of pain behaviors during the acute and chronic phases of inflammation in both young and aged mice. We found that both young (2 months old) and aged (>18 months old) mice exhibited prominent pain behaviors during both acute (2 day) and chronic (8 week) inflammation. However, young mice exhibited greater behavioral sensitization to mechanical stimuli than their aged counterparts. Teased fiber recordings in young animals revealed a twofold mechanical sensitization in C fibers during acute inflammation, but an unexpected twofold reduction in firing during chronic inflammation. Responsiveness to capsaicin and mechanical responsiveness of A-mechanonociceptor (AM) fibers were also reduced chronically. Importantly, this lack of sensitization in afferent firing during chronic inflammation occurred even as these inflamed mice exhibited continued behavioral sensitization. Interestingly, C fibers from inflamed aged animals showed no change in mechanical firing compared with controls during either the acute or chronic inflammatory phases, despite strong behavioral sensitization to mechanical stimuli at these time points. These results reveal the following two important findings: (1) nociceptor sensitization to mechanical stimulation depends on age and the chronicity of injury; and (2) maintenance of chronic inflammatory pain does not rely on enhanced peripheral drive.Entities:
Keywords: acute pain; aging; chronic pain; mechanical; sensitization; skin–nerve preparation
Mesh:
Substances:
Year: 2016 PMID: 26866058 PMCID: PMC4745182 DOI: 10.1523/ENEURO.0115-15.2015
Source DB: PubMed Journal: eNeuro ISSN: 2373-2822
Context sequences for primers used for qRT-PCR
| Mm00450762_s1 | ACGAAAGCAGGAAATAGAGCTTCGG | |
| Mm00501467_m1 | TCCACTCCTGGTTCTCCATATTTAT | |
| Mm00449367_m1 | TCTGTAATCTCAGGTCTGAAGGTCA | |
| Mm01265861_m1 | ACAAGAGCCTCTTGTGCAAGAGGAG | |
| Mm01227437_m1 | GAAGAAGGGAACACAGCACTCCACT | |
| Mm01246302_m1 | TACTTTTCTTTGTACAGTCACTGTT | |
| Mm00444690_m1 | CCTTGTAGCAGGCTGGGGAAGATTC | |
| Mm01176083_m1 | TACCCCAGCTTCCGGGGTAATGAAA | |
| Mm00439977_s1 | TGCGGCCGCACGCTCCCTGCCCCAC | |
| Mm00440080_m1 | CCACGCCTACGTGTTCCTTTTAGTC | |
| Mm00548884_m1 | TGTGCCCACAGCAAAGAACTCATCA | |
| Mm00446971_m1 | TCCCCACAGGGCGCCATGACTCCTG |
Statistical tests utilized in this manuscript
| Non-normally distributed | Mann Whitney Test | −1.982 to 0 | ||||
| Normally Distributed | 2-way repeated measures ANOVA | BL | −1.786 to 0.9921 | |||
| 2 Days | 1.399 to 4.177 | |||||
| 2 Weeks | 1.116 to 3.894 | |||||
| 3 Week | 0.6599 to 3.438 | |||||
| 4 Weeks | 1.513 to 4.291 | |||||
| 6 Weeks | 1.053 to 3.831 | |||||
| 8 Weeks | 0.9196 to 3.698 | |||||
| Normally Distributed | 2-way repeated measures ANOVA | BL | −1.895 to 1.047 | |||
| 2 Days | −3.114 to −0.1722 | |||||
| 2 Weeks | −3.073 to −0.1315 | |||||
| 3 Weeks | −3.467 to −0.5257 | |||||
| 4 Weeks | −3.824 to −0.8828 | |||||
| 6 Weeks | −3.708 to −0.7663 | |||||
| 8 Weeks | −3.797 to −0.8067 | |||||
| Normally Distributed | 2-way repeated measures ANOVA | BL | −2.017 to −0.6001 | |||
| 2 Days | −0.1975 to 1.219 | |||||
| 2 Weeks | 0.2870 to 1.704 | |||||
| 3 Weeks | −0.1994 to 1.218 | |||||
| 4 Weeks | −0.1833 to 1.234 | |||||
| 6 Weeks | −0.2278 to 1.189 | |||||
| 8 Weeks | −0.5649 to 0.8520 | |||||
| Normally Distributed | 2-way repeated measures ANOVA | BL | −6.579 to 70.27 | |||
| 2 Days | 15.50 to 92.35 | |||||
| 2 Weeks | −2.743 to 74.11 | |||||
| 3 Weeks | −0.06598 to 76.78 | |||||
| 4 Weeks | −0.1534 to 76.70 | |||||
| 6 Weeks | −18.63 to 58.22 | |||||
| 8 Weeks | −6.579 to 70.27 | |||||
| Normally Distributed | Student’s t-test | −12.04 to 8.812 | ||||
| Normally Distributed | 2-way repeated measures ANOVA | BL | −19.12 to 9.119 | |||
| 2 Days | 31.71 to 59.95 | |||||
| 2 Weeks | 27.96 to 56.20 | |||||
| 3 Weeks | 35.05 to 63.29 | |||||
| 4 Weeks | 31.30 to 59.54 | |||||
| 6 Weeks | 31.30 to 59.54 | |||||
| 8 Weeks | 31.30 to 59.54 | |||||
| Normally Distributed | 2-way repeated measures ANOVA | BL | −30.63 to 19.91 | |||
| 2 Days | −20.39 to 30.15 | |||||
| 2 Weeks | −14.44 to 36.10 | |||||
| 3 Weeks | 7.705 to 58.25 | |||||
| 4 Weeks | 15.32 to 65.87 | |||||
| 6 Weeks | 11.63 to 62.18 | |||||
| 8 Weeks | 10.93 to 62.31 | |||||
| Normally Distributed | 2-way repeated measures ANOVA | BL | −17.81 to 23.52 | |||
| 2 Days | 1.122 to 42.45 | |||||
| 2 Weeks | 8.086 to 49.41 | |||||
| 3 Weeks | −10.31 to 31.02 | |||||
| 4 Weeks | −13.34 to 27.99 | |||||
| 6 Weeks | −10.49 to 30.84 | |||||
| 8 Weeks | −22.63 to 18.70 | |||||
| Normally Distributed | 1-way ANOVA | 0.8595 to 1.648 for Young height | ||||
| 0.2179 to 1.028 for Aged height | ||||||
| 0.3473 to 1.482 for Young width | ||||||
| 0.4451 to 1.610 for Aged height | ||||||
| Normally Distributed | 2-way ANOVA | 15.00 mN | −2.979 to 1.547 | |||
| 35.00 mN | −2.442 to 2.084 | |||||
| 70.00 mN | 1.031 to 5.556 | |||||
| 140.0 mN | 3.124 to 7.650 | |||||
| Normally Distributed | 2-way ANOVA | 15.00 mN | −2.376 to 2.028 | |||
| 35.00 mN | −2.117 to 2.287 | |||||
| 70.00 mN | −0.5504 to 3.854 | |||||
| 140.0 mN | −0.3346 to 4.101 | |||||
| Normally Distributed | 2-way ANOVA | 15.00 mN | −1.645 to 2.507 | |||
| 35.00 mN | −1.791 to 2.361 | |||||
| 70.00 mN | −3.398 to 0.7536 | |||||
| 140.0 mN | −5.603 to −1.451 | |||||
| Non-Normally Distributed | Kruskal-Wallis Test | Aged CFA − 2 days vs Aged PBS − 2 days | −0.3564 to 0.4208 | |||
| Aged CFA − 2 days vs Young CFA − 2 days | −0.3346 to 0.4188 | |||||
| Aged CFA − 2 days vs Young PBS − 2 days | −0.2396 to 0.5376 | |||||
| Aged PBS − 2 days vs Young CFA − 2 days | −0.3906 to 0.4105 | |||||
| Aged PBS − 2 days vs Young PBS − 2 days | −0.2949 to 0.5285 | |||||
| Young CFA − 2 days vs Young PBS − 2 days | −0.2937 to 0.5074 | |||||
| Non-Normally Distributed | Contingency Table followed by Fisher’s Exact Test | 1.081 to 10.12 for Aged Odds Ratio | ||||
| 0.9011 to 8.377 for Young Odds Ratio | ||||||
| (95% CI cannot be calculated for Fisher’s Exact test alone) | ||||||
| Normally Distributed | 2-way ANOVA | 15.00 mN | −3.588 to 0.02884 | |||
| 35.00 mN | −3.934 to −0.3170 | |||||
| 70.00 mN | −3.356 to 0.2608 | |||||
| 140.0 mN | −1.688 to 2.081 | |||||
| Normally Distributed | 2-way ANOVA | 15.00 mN | −3.198 to 1.455 | |||
| 35.00 mN | −3.370 to 1.284 | |||||
| 70.00 mN | −3.109 to 1.544 | |||||
| 140.0 mN | −2.994 to 1.691 | |||||
| Normally Distributed | 2-way ANOVA | 15.00 mN | −1.302 to 2.701 | |||
| 35.00 mN | −0.3710 to 3.632 | |||||
| 70.00 mN | 2.282 to 6.286 | |||||
| 140.0 mN | 1.971 to 6.009 | |||||
| Normally Distributed | 2-way ANOVA | 15.00 mN | −2.522 to 1.914 | |||
| 35.00 mN | −3.274 to 1.162 | |||||
| 70.00 mN | −5.297 to −0.8607 | |||||
| 140.0 mN | −5.677 to −1.170 | |||||
| Non-Normally Distributed | Kruskal-Wallis Test | Aging PBS vs CFA | 0.1826 to 1.322 | |||
| Young PBS vs CFA | 0.4658 to 1.511 | |||||
| Non-Normally Distributed | Contingency Table followed by Fisher’s Exact Test | 1.590 to 15.73 for Young Odds Ratio | ||||
| 0.5893 to 5.284 for Aged Odds Ratio | ||||||
| (95% CI cannot be calculated for Fisher’s Exact test alone) | ||||||
| Non-Normally Distributed | Contingency Table followed by Fisher’s Exact Test | 1.770 to 2.348 for Young 2-day CFA vs PBS Odds Ratio | ||||
| 1.597 to 1.995 for Aged 2-day CFA vs PBS Odds Ratio | ||||||
| (95% CI cannot be calculated for Fisher’s Exact test alone) | ||||||
| Normally Distributed | One-way ANOVA | CFA - 8 wk vs PBS - 8 wk | 0.05562 to 0.1652 | |||
| CFA 2 days vs PBS - 2 days | −0.1246 to −0.01475 | |||||
| Aged - 8 wk PBS vs Aged 8 wk CFA | −0.06385 to 0.01858 | |||||
| Aged 2 day CFA vs Aged 2 day PBS | 0.03960 to 0.1341 | |||||
| Normally Distributed | One-way ANOVA | Aged 8 Wk CFA vs Aged 8 Wk PBS | −0.7127 to 0.9026 | |||
| Aged 8 Wk CFA vs Aged 2 day CFA | −0.4550 to 1.054 | |||||
| Aged 8 Wk CFA vs Aged 2 day PBS | −0.7648 to 0.8323 | |||||
| Aged 8 Wk CFA vs Young 8 week CFA | −0.5910 to 0.9439 | |||||
| Aged 8 Wk CFA vs Young 8 week PBS | −1.376 to 0.2588 | |||||
| Aged 8 Wk CFA vs Young 2 days CFA | −0.4760 to 1.073 | |||||
| Aged 8 Wk CFA vs Young 2 days PBS | −0.6258 to 0.9712 | |||||
| Aged 8 Wk PBS vs Aged 2 day CFA | −0.6031 to 1.012 | |||||
| Aged 8 Wk PBS vs Aged 2 day PBS | −0.9101 to 0.7877 | |||||
| Aged 8 Wk PBS vs Young 8 week CFA | −0.7382 to 0.9013 | |||||
| Aged 8 Wk PBS vs Young 8 week PBS | −1.520 to 0.2131 | |||||
| Aged 8 Wk PBS vs Young 2 days CFA | −0.6228 to 1.030 | |||||
| Aged 8 Wk PBS vs Young 2 days PBS | −0.7712 to 0.9267 | |||||
| Aged 2 day CFA vs Aged 2 day PBS | −1.064 to 0.5327 | |||||
| Aged 2 day CFA vs Young 8 week CFA | −0.8905 to 0.6444 | |||||
| Aged 2 day CFA vs Young 8 week PBS | −1.676 to −0.04072 | |||||
| Aged 2 day CFA vs Young 2 days CFA | −0.7755 to 0.7735 | |||||
| Aged 2 day CFA vs Young 2 days PBS | −0.9253 to 0.6717 | |||||
| Aged 2 day PBS vs Young 8 week CFA | −0.6680 to 0.9535 | |||||
| Aged 2 day PBS vs Young 8 week PBS | −1.451 to 0.2658 | |||||
| Aged 2 day PBS vs Young 2 days CFA | −0.5526 to 1.082 | |||||
| Aged 2 day PBS vs Young 2 days PBS | −0.7013 to 0.9792 | |||||
| Young 8 week CFA vs Young 8 week PBS | −1.565 to 0.09424 | |||||
| Young 8 week CFA vs Young 2 days CFA | −0.6650 to 0.9091 | |||||
| Young 8 week CFA vs Young 2 days PBS | −0.8145 to 0.8069 | |||||
| Young 8 week PBS vs Young 2 days CFA | 0.02128 to 1.693 | |||||
| Young 8 week PBS vs Young 2 days PBS | −0.1269 to 1.590 | |||||
| Young 2 days CFA vs Young 2 days PBS | −0.9432 to 0.6916 | |||||
| Normally Distributed | Chi Square followed by Fisher’s exact test | 1.342 to 24.34 for naive vs 8-week CFA Odds Ratio | ||||
| 1.111 to 21.82 for 2-day CFA vs 8-week CFA Odds Ratio | ||||||
| (95% CI cannot be calculated for Fisher’s Exact test alone) | ||||||
| Normally Distributed | 1-way ANOVA | Naive vs 2-day CFA | −31.44 to 46.29 | |||
| Naive vs 8-week CFA | −21.96 to 85.90 | |||||
| 2-day CFA vs 8-week CFA | −30.92 to 80.01 | |||||
| Normally Distributed | Chi Square | 0.2197 to 31.37 for naïve vs 2-day Odds Ratio | ||||
| 0.03641 to 6.866 for 2-day vs 8-week Odds Ratio | ||||||
| 0.1677 to 10.27 for naïve vs 8-week Odds Ratio | ||||||
| (95% CI cannot be calculated for Fisher’s Exact test alone) | ||||||
| Normally Distributed | 1-way ANOVA | Naive vs 2-day | −99.31 to 0.3113 | |||
| Naive vs 8-week | −90.56 to 9.061 | |||||
| 2-day vs 8-week | −41.06 to 58.56 | |||||
| Normally Distributed | 2-way ANOVA | Naive vs 2-day | ||||
| Force | ||||||
| 15.00 | −8.125 to 1.035 | |||||
| 35.00 | −7.587 to 1.573 | |||||
| 70.00 | −7.013 to 2.147 | |||||
| 140.0 | −6.602 to 2.701 | |||||
| Naive vs 8 week | ||||||
| Force | −7.934 to 2.113 | |||||
| 15.00 | −8.314 to 1.732 | |||||
| 35.00 | −8.317 to 1.729 | |||||
| 70.00 | −7.230 to 2.816 | |||||
| 140.0 | −7.934 to 2.113 | |||||
| 2-day vs 8 week | ||||||
| Force | ||||||
| 15.00 | −4.665 to 5.935 | |||||
| 35.00 | −5.584 to 5.017 | |||||
| 70.00 | −6.161 to 4.440 | |||||
| 140.0 | −5.619 to 5.106 | |||||
| Non-Normally Distributed | Kruskall Wallis Test | Naïve | 2-day | 8-week | ||
| Lower 95% CI | 0.4476 | 0.7617 | 0.9286 | |||
| Upper 95% CI | 0.8724 | 1.083 | 1.929 | |||
| Normally Distributed | Student’s t-test for PBS vs CFA for each time point and gene | −0.9854 to −0.1312 Young 2-day Nav1.7 | ||||
| −1.848 to 0.07474 Young 2-day Nav1.8 | ||||||
| −1.643 to 0.4202 Young 2-day Nav1.9 | ||||||
| −1.886 to 0.2060 Young 2-day Piezo2 | ||||||
| −2.157 to −0.7731 Young 2-day TRPA1 | ||||||
| −1.294 to 0.06031 Young 2-day TRPV1 | ||||||
| −1.014 to 0.1110 Young 2-day TRPC3 | ||||||
| 0.007134 to 1.246 Young 2-day TRPC6 | ||||||
| −1.581 to 0.6142 Young 2-day Kv1.1 | ||||||
| −1.399 to 0.07587 Young 2-day Kv7.2 | ||||||
| −1.710 to −0.06359 Young 2-day Kv7.3 | ||||||
| −0.6277 to 0.7177 Young 8-week Nav1.7 | ||||||
| −0.9606 to 0.4572 Young 8-week Nav1.8 | ||||||
| −0.8359 to 0.6292 Young 8-week Nav1.9 | ||||||
| −1.141 to 0.8441 Young 8-week Piezo2 | ||||||
| −0.7882 to 0.4815 Young 8-week TRPA1 | ||||||
| −0.9529 to 0.4529 Young 8-week TRPV1 | ||||||
| −1.469 to 0.8719 Young 8-week TRPC3 | ||||||
| −0.5417 to 1.498 Young 8-week TRPC6 | ||||||
| −0.7716 to 0.1383 Young 8-week Kv1.1 | ||||||
| −1.292 to 0.4155 Young 8-week Kv7.2 | ||||||
| −1.370 to 0.3438 Young 8-week Kv7.3 | ||||||
| −0.6742 to 0.5142 Aged 2-day Nav1.7 | ||||||
| −0.9797 to 0.9464 Aged 2-day Nav1.8 | ||||||
| −0.9318 to 1.192 Aged 2-day Nav1.9 | ||||||
| −0.8022 to 0.4022 Aged 2-day Piezo2 | ||||||
| −2.579 to −0.4873 Aged 2-day TRPA1 | ||||||
| −1.068 to 0.08780 Aged 2-day TRPV1 | ||||||
| 0.02838 to 0.9250 Aged 2-day TRPC3 | ||||||
| −0.5024 to 1.082 Aged 2-day TRPC6 | ||||||
| −0.07159 to 0.5116 Aged 2-day Kv1.1 | ||||||
| −0.4090 to 0.6290 Aged 2-day Kv7.2 | ||||||
| −0.4557 to 0.5357 Aged 2-day Kv7.3 | ||||||
| −0.3108 to 0.5842 Aged 8-week Nav1.7 | ||||||
| −0.7250 to 0.02833 Aged 8-week Nav1.8 | ||||||
| −0.6878 to 0.1078 Aged 8-week Nav1.9 | ||||||
| −0.7805 to 0.3605 Aged 8-week Piezo2 | ||||||
| −1.981 to −0.4358 Aged 8-week TRPA1 | ||||||
| −0.7546 to −0.03539 Aged 8-week TRPV1 | ||||||
| −0.6783 to 0.8150 Aged 8-week TRPC3 | ||||||
| −1.052 to 0.8521 Aged 8-week TRPC6 | ||||||
| −0.1824 to 0.8290 Aged 8 week Kv1.1 | ||||||
| −0.5183 to 0.6183 Aged 8 week Kv7.2 | ||||||
| −0.4955 to 0.6255 Aged 8 week Kv7.3 | ||||||
| Normally Distributed | One-way ANOVA | Nav1.7 | ||||
| Aged 2-day vs Aged 8 weeks | −0.2611 to 0.5441 | |||||
| Aged 2-day vs Young 2-day | −0.8386 to −0.03346 | |||||
| Aged 8 weeks vs Young 8 week | −0.3855 to 0.2719 | |||||
| Young 2-day vs Young 8 week | 0.1920 to 0.8494 | |||||
| Nav1.8 | ||||||
| Aged 2-day vs Aged 8 weeks | −1.284 to 0.7893 | |||||
| Aged 2-day vs Young 2-day | −2.104 to −0.03105 | |||||
| Aged 8 weeks vs Young 8 week | −0.7631 to 0.9298 | |||||
| Young 2-day vs Young 8 week | 0.05728 to 1.750 | |||||
| Nav1.9 | ||||||
| Aged 2-day vs Aged 8 weeks | −1.233 to 0.6500 | |||||
| Aged 2-day vs Young 2-day | −1.694 to 0.1896 | |||||
| Aged 8 weeks vs Young 8 week | −0.6290 to 0.9088 | |||||
| Young 2-day vs Young 8 week | −0.1685 to 1.369 | |||||
| Piezo2 | ||||||
| Aged 2-day vs Aged 8 weeks | −1.071 to 1.067 | |||||
| Aged 2-day vs Young 2-day | −1.880 to 0.2578 | |||||
| Aged 8 weeks vs Young 8 week | −0.8390 to 0.9063 | |||||
| Young 2-day vs Young 8 week | −0.03008 to 1.715 | |||||
| TRPA1 | ||||||
| Aged 2-day vs Aged 8 weeks | −0.8925 to 2.265 | |||||
| Aged 2-day vs Young 2-day | −1.406 to 1.752 | |||||
| Aged 8 weeks vs Young 8 week | −0.04212 to 2.536 | |||||
| Young 2-day vs Young 8 week | −0.4714 to 3.050 | |||||
| TRPV1 | ||||||
| Aged 2-day vs Aged 8 weeks | −0.6561 to 0.7992 | |||||
| Aged 2-day vs Young 2-day | −0.9202 to 0.5352 | |||||
| Aged 8 weeks vs Young 8 week | −0.4682 to 0.7201 | |||||
| Young 2-day vs Young 8 week | −0.2041 to 0.9841 | |||||
| TRPC3 | ||||||
| Aged 2-day vs Aged 8 weeks | −1.036 to 0.4285 | |||||
| Aged 2-day vs Young 2-day | −1.465 to −0.0002279 | |||||
| Aged 8 weeks vs Young 8 week | −0.8156 to 0.3804 | |||||
| Young 2-day vs Young 8 week | −0.3868 to 0.8092 | |||||
| TRPC6 | ||||||
| Aged 2-day vs Aged 8 weeks | −0.3808 to 0.8767 | |||||
| Aged 2-day vs Young 2-day | −0.3464 to 0.9110 | |||||
| Aged 8 weeks vs Young 8 week | −0.3308 to 0.6959 | |||||
| Young 2-day vs Young 8 week | −0.3651 to 0.6616 | |||||
| Kv1.1 | ||||||
| Aged 2-day vs Aged 8 weeks | −0.9476 to 1.019 | |||||
| Aged 2-day vs Young 2-day | −1.693 to 0.2736 | |||||
| Aged 8 weeks vs Young 8 week | −1.234 to 0.3716 | |||||
| Young 2-day vs Young 8 week | −0.4887 to 1.117 | |||||
| Kv7.2 | ||||||
| Aged 2-day vs Aged 8 weeks | −0.9518 to 0.8372 | |||||
| Aged 2-day vs Young 2-day | −1.666 to 0.1225 | |||||
| Aged 8 weeks vs Young 8 week | −1.099 to 0.3614 | |||||
| Young 2-day vs Young 8 week | −0.3847 to 1.076 | |||||
| Kv7.3 | ||||||
| Aged 2-day vs Aged 8 weeks | −1.049 to 1.010 | |||||
| Aged 2-day vs Young 2-day | −2.029 to 0.02973 | |||||
| Aged 8 weeks vs Young 8 week | −1.274 to 0.4071 | |||||
| Young 2-day vs Young 8 week | −0.2940 to 1.387 | |||||
Figure 1.Acute and chronic inflammation sensitizes behavioral responses to mechanical stimuli to different extents in young and aged mice. , Paw withdrawal thresholds to a mechanical stimulus are lower in aged animals (2.35 mN) compared with young animals (3.23 mN) at baseline. , , Injection of CFA results in a dramatic reduction in paw withdrawal thresholds both acutely and chronically in young () and aged () mice compared with PBS injection. , Young mice exhibit a greater reduction in paw withdrawal thresholds compared with aged mice. , As a percentage of baseline, young mice exhibit a >90% reduction in paw withdrawal thresholds, while aged mice exhibit a 40-75% reduction in paw withdrawal thresholds. , Baseline responses to a 3.61 mN suprathreshold stimulus are similar between young and aged mice. , , Injection of CFA results in a significant elevation in the percentage of response to a suprathreshold 3.61 mN stimulus in both young () and aged () mice. , In response to the injection of CFA, aged mice respond with elevations in the percentage response to a suprathreshold stimulus on a different time course than young mice. , Chronically inflamed mice continue to exhibit significant paw swelling at 8 weeks after inflammation induction. , Top row, H&E-stained coronal sections through the entire paw at the metatarsophalangeal joint from young animals show significant inflammatory infiltrate present at both 2 days and 8 weeks after CFA injection. Bottom row, Increased magnification of the whole-paw sections demonstrate significant infiltration of neutrophils and monocytes/macrophages at both 2 days and 8 weeks of CFA-mediated inflammation.
Figure 2.Acute inflammation sensitizes C-fiber nociceptors to mechanical force only in young animals. , Trace examples from young animals injected with either PBS (top left) or CFA (bottom left) and aged animals injected with either PBS (top right) or CFA (bottom right). , C-fiber nociceptors from acutely inflamed (2 day) young animals respond with significantly higher action potential firing rates in response to increasing mechanical forces. , C-fiber nociceptors from acutely inflamed aged animals trend toward responding with increased action potential firing in response to increasing mechanical forces, but this relationship is not significant. , At baseline, C fibers from aged animals are more sensitive to mechanical stimuli than C fibers from young animals. , von Frey thresholds for individual C fibers were not different between the four cohorts. Each point on the graph represents the von Frey threshold of an individual C fiber, and the black bars are indicative of the group mean. , More C fibers from acutely inflamed animals tend to have ongoing, nonevoked activity (>0.05 Hz), although this relationship is not significant.
Figure 3.Chronic inflammation results in a desensitization of C fibers to mechanical force in young, but not aged animals. , Trace examples from young animals injected with either PBS (top left) or CFA (bottom left) and aged animals injected with either PBS (top right) or CFA (bottom right). , After 8 weeks of inflammation, C fibers from young animals respond with significantly lower action potential firing rates in response to increasing mechanical forces. , After 8 weeks of inflammation, C fibers from aged animals trend toward lower firing rates in response to increasing mechanical forces. , The firing rates of C fibers from inflamed young animals are significantly lower after 8 weeks of chronic inflammation compared with 2 days of acute inflammation. , The firing rates of C fibers from inflamed aged animals are significantly lower after 8 weeks of chronic inflammation compared with 2 days of acute inflammation. , , Plots of the firing rates of individual C fibers at different forces for each cohort for young () and aged () animals. Note that after 2 days of acute inflammation the entire population of C fibers in both young and aged animals shifts toward elevated firing rates, rather than only a subpopulation of increased responders. , von Frey thresholds for individual C fibers are elevated in both young and aged animals after 8 weeks of chronic inflammation. Each point on the graph represents the von Frey threshold of an individual C fiber, and the black bars are indicative of the group mean. , Chronic inflammation results in an increased percentage of C fibers demonstrating ongoing, nonevoked activity in young animals, but not in aged animals.
Figure 4.C-fiber action potential firing patterns do not explain the significant behavioral sensitization, but reduction in action potential firing rates during chronic inflammation. , Grouped instantaneous firing rates over the 12 s mechanical stimulus binned into 200 ms intervals for fibers from young acutely inflamed animals (), aged acutely inflamed animals (), young chronically inflamed animals (), and aged chronically inflamed animals (). , C fibers from acutely inflamed young and aged animals fired with a significantly higher percentage of interspike intervals between 0 and 99 ms. , The CV2 for a 140 mN stimulus were significantly different for C fibers from acutely inflamed young and aged animals, and chronically inflamed young animals, but these relationships do not consistently demonstrate that variability may underlie the increased behavioral sensitization seen acutely and chronically. , The time to first action potential after the onset of the mechanical stimulus is not different for any of the cohorts.
Figure 5.C-fiber responses to capsaicin are reduced during chronic inflammation, while behavioral sensitization to capsaicin remains intact. , C-fiber responses to capsaicin are similar under naïve and acutely inflamed conditions in young animals, but responses are strongly attenuated during chronic inflammation. , The number of action potentials fired by capsaicin-sensitive C fibers is also reduced after 8 weeks of chronic inflammation in young animals (although this is not statistically significant). , In aged animals, C-fiber responses to capsaicin are similar across the naïve, acute inflamed, and chronic inflamed states. Note the low numbers that are due to the lack of aged animal availability. , Number of action potentials fired by aged C fibers in response to capsaicin. , Young animals exhibit sensitized pain behaviors in response to capsaicin injection during both acute inflammatory and chronic inflammatory states, despite the reduced afferent responses to capsaicin at 8 weeks.
Figure 6.AM fibers from young animals exhibit reduced mechanical firing rates following inflammation. , Following both 2 day acute and 8 week chronic inflammation, AM fibers from young animals exhibit reduced firing rates in response to mechanical stimuli. , Plots of the firing rates of individual AM fibers at different forces for each cohort of young animals. Note the loss of a population of high-responding AM fibers at the 2 day and 8 week time points. , von Frey thresholds of individual AM fibers from young animals are elevated after 8 weeks of chronic inflammation compared with fibers from naïve animals.
Figure 7.Changes in gene expression of voltage-gated and mechanosensitive ion channels do not explain the reduced action potential firing after 8 weeks of chronic inflammation. , Gene expression for voltage-gated sodium channels NaV1.7 (Scn9a), NaV1.8 (Scn10a), and NaV1.9 (Scn11a). Bars indicate the fold change of the CFA condition over the PBS condition for each cohort. The red dotted line indicates a fold change of 1, meaning no change in expression levels between CFA and PBS conditions. *Indicates significant fold changes for the CFA vs PBS condition; #indicates significant differences in the fold change between cohorts. , Gene expression (shown as fold change compared with PBS controls) for Piezo2 (Fam38b) and TRP channels. , Gene expression (shown as the fold change compared with PBS controls) for voltage-gated potassium channels KV1.1 (Kcna1), KV7.2 (Kcnq2), and KV7.3 (Kcnq3).